Globeflex Capital L P Collegium Pharmaceutical, Inc Transaction History

Globeflex Capital L P

$946 Million
Q2 2024

A detailed history of Globeflex Capital L P transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Globeflex Capital L P holds 52,938 shares of COLL stock, worth $2.05 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

52,938

Previous 60,070 11.87%

Holding current value

$2.05 Million

Previous $2.33 Million 26.9%

% of portfolio

0.18%

Previous 0.23%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$31.36 - $39.99 $223,659 - $285,208	-7,132 Reduced 11.87%	52,938 $1.7 Million
Q1 2024 May 14, 2024	BUY	$31.23 - $40.91 $494,277 - $647,482	15,827 Added 35.77%	60,070 $2.33 Million
Q3 2023 Nov 13, 2023	SELL	$21.23 - $24.28 $25,964 - $29,694	-1,223 Reduced 2.69%	44,243 $988,000
Q2 2023 Aug 14, 2023	SELL	$21.06 - $24.0 $37,549 - $42,792	-1,783 Reduced 3.77%	45,466 $977,000
Q1 2021 May 14, 2021	SELL	$19.25 - $26.1 $350,581 - $475,333	-18,212 Reduced 27.82%	47,249 $1.12 Million
Q4 2020 Feb 11, 2021	SELL	$17.83 - $22.29 $635,960 - $795,039	-35,668 Reduced 35.27%	65,461 $1.31 Million
Q3 2020 Nov 13, 2020	BUY	$15.78 - $20.82 $29,650 - $39,120	1,879 Added 1.89%	101,129 $2.11 Million
Q2 2020 Aug 12, 2020	BUY	$15.49 - $23.51 $14,622 - $22,193	944 Added 0.96%	99,250 $1.74 Million
Q1 2020 May 13, 2020	BUY	$13.89 - $25.45 $158,012 - $289,519	11,376 Added 13.09%	98,306 $1.61 Million
Q4 2019 Feb 07, 2020	BUY	$10.7 - $22.24 $19,837 - $41,232	1,854 Added 2.18%	86,930 $1.79 Million
Q2 2019 Aug 12, 2019	BUY	$10.62 - $16.59 $903,507 - $1.41 Million	85,076 New	85,076 $1.12 Million

Others Institutions Holding COLL

# of Institutions

236

Shares Held

39.4M

Call Options Held

84.2K

Put Options Held

18.6K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.32B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Globeflex Capital L P, based on Form 13F filings with the SEC.

News

Stay updated on Globeflex Capital L P with notifications on news.

Account

Globeflex Capital L P Collegium Pharmaceutical, Inc Transaction History